PATENT CLAIM ANALYSIS

Application Number: 15535222
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["436", "064000"]

Abstract:
The present disclosure is drawn to methods of diagnosing and classifying pancreatic cancer by examining the expression of particular metabolites that distinguish this disease state from benign disease and periampullary adenocarcinoma.

Claim (Index 11):
The method of  claim 1 , wherein said levels are compared to a pre-determined standard.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 86.0
- Lexical Diversity: 1.10345
- Patent Class: 436.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14671062', '14753249', '14632480', '13371969', '15116272']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6530551301251973
- 35 USC 102 Novelty (BERT): 0.4904752748791992
- Combined Prediction Score: 0.6367971446005976
- Mean Citation Score: 182.267954
- Max Citation Score: 185.58125
- Similarity Product: 110.10607182644308

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test